1. The intriguing diversity of the glucagon gene products

   • Pierre J. Lefèbvre

   Invited Commentary Pages: 201 - 202

2. Literature alert

   Abstract Pages: 203 - 203

3. Web alert

   • Vanessa G. Carroll

   News Pages: 204 - 204

4. Action for health in diabetes: The Look AHEAD clinical trial

   • David E. Kelley

   Clinical Trials Report Pages: 207 - 209

5. Hepatic steatosis and type 2 diabetes mellitus

   • Jeanne M. Clark
   • Anna Mae Diehl

   OriginalPaper Pages: 210 - 215

6. Skeletal muscle triglyceride: Marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?

   • Bret H. Goodpaster
   • David E. Kelley

   OriginalPaper Pages: 216 - 222

7. Emerging paradigms for understanding fatness and diabetes risk

   • Steven R. Smith
   • Eric Ravussin

   OriginalPaper Pages: 223 - 230

8. Is hepatic glucose production increased in type 2 diabetes mellitus?

   • Henning Beck-Nielsen
   • Ole Hother-Nielsen
   • Peter Staehr

   OriginalPaper Pages: 231 - 236

9. Role of the kidney in hyperglycemia in type 2 diabetes

   • Christian Meyer
   • John E. Gerich

   OriginalPaper Pages: 237 - 241

10. Progression from IGT to type 2 diabetes mellitus: The central role of impaired early insulin secretion

    • Richard E. Pratley
    • Christian Weyer

    OriginalPaper Pages: 242 - 248

11. Role of ACE Inhibitors in treating hypertensive diabetic patients

    • Dmitri Kirpichnikov
    • James R. Sowers

    OriginalPaper Pages: 251 - 257

12. Microalbuminuria in diabetes: Focus on cardiovascular and renal risk reduction

    • George L. Bakris
    • James R. Sowers

    OriginalPaper Pages: 258 - 262

13. Cardiovascular risk factors in diabetic patients with hypertension

    • Nathaniel Winer
    • James R. Sowers

    OriginalPaper Pages: 263 - 266

14. Heart protection study: LDL lowering therapy and cardiovascular outcomes in patients with low cholesterol levels or diabetes

    • Mrinalini Kulkarni
    • Peter D. Reaven

    Clinical Trials Report Pages: 269 - 273

15. The epidemiology of atherosclerosis and its risk factors among Native Americans

    • James M. Galloway

    OriginalPaper Pages: 274 - 281

16. The role of non-LDL:non-HDL particles in atherosclerosis

    • Jere P. Segrest

    OriginalPaper Pages: 282 - 288

17. The effect of dietary intervention on serum lipid levels in type 2 diabetes mellitus

    • Nilo B. Cater
    • Abhimanyu Garg

    OriginalPaper Pages: 289 - 294